Trademark: 87691768
Word
TOZARIDE
Status
Registered
Status Code
700
Status Date
Tuesday, January 8, 2019
Serial Number
87691768
Registration Number
5650970
Registration Date
Tuesday, January 8, 2019
Mark Type
4000
Filing Date
Monday, November 20, 2017
Published for Opposition
Tuesday, April 17, 2018

Trademark Owner History
Andarix Pharmaceuticals, Inc. - Original Registrant

Classifications
5 Peptide-based pharmaceutical preparations for the treatment of lung cancer

Trademark Events
Jan 8, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jan 8, 2019
Registered-Principal Register
Dec 7, 2018
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 6, 2018
Allowed Principal Register - Sou Accepted
Dec 3, 2018
Statement Of Use Processing Complete
Nov 16, 2018
Use Amendment Filed
Dec 3, 2018
Case Assigned To Intent To Use Paralegal
Nov 16, 2018
Teas Statement Of Use Received
Jun 12, 2018
Noa E-Mailed - Sou Required From Applicant
Apr 17, 2018
Official Gazette Publication Confirmation E-Mailed
Apr 17, 2018
Published For Opposition
Mar 28, 2018
Notification Of Notice Of Publication E-Mailed
Mar 15, 2018
Assigned To Lie
Mar 5, 2018
Approved For Pub - Principal Register
Mar 5, 2018
Examiner's Amendment Entered
Mar 5, 2018
Notification Of Examiners Amendment E-Mailed
Mar 5, 2018
Examiners Amendment E-Mailed
Mar 5, 2018
Examiners Amendment -Written
Mar 5, 2018
Assigned To Examiner
Dec 2, 2017
New Application Office Supplied Data Entered

Trademark Alertz updated from USPTO on 2030-01-24